🇺🇸 Pegylated Interferon alpha-2a in United States

20 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Anorexia — 2 reports (10%)
  2. Ascites — 2 reports (10%)
  3. Back Pain — 2 reports (10%)
  4. Diarrhoea — 2 reports (10%)
  5. Drug Intolerance — 2 reports (10%)
  6. Dry Mouth — 2 reports (10%)
  7. Hepatic Failure — 2 reports (10%)
  8. Jaundice — 2 reports (10%)
  9. Oedema — 2 reports (10%)
  10. Renal Failure — 2 reports (10%)

Source database →

Frequently asked questions

Is Pegylated Interferon alpha-2a approved in United States?

Pegylated Interferon alpha-2a does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Pegylated Interferon alpha-2a in United States?

ANRS, Emerging Infectious Diseases is the originator. The local marketing authorisation holder may differ — check the official source linked above.